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Background: We aimed to quantify the frequency of HIV serosorting among men who have sex with 
men (MSM) in Germany, and evaluate the association of serosorting with other sexual risk 
management approaches (RMA) and with the frequency of bacterial sexually transmissible infections 
(STI).  
Methods: An anonymous, self-administered questionnaire was distributed through German online 
sexual networking sites and medical practices in 2006. The analysis was based on 2985 respondents 
who reported an HIV test result. Based on two questions on RMA, serosorting was classified as 
tactical (an event-based decision) or strategic (a premeditated search for a seroconcordant partner). 
The analysis was stratified by HIV serostatus and seroconcordant partnership status.  
Results: HIV serosorting patterns were different for HIV-positive and HIV-negative participants. 
Tactical serosorting ranked second after RMA based on condom use (HIV-positive: 55.1%, HIV-
negative: 45.1%; P < 0.001). While the overlap of strategic and tactical HIV serosorting among HIV-
positive MSM was substantial (58.0%), HIV-negative strategic and tactical serosorting were more 
distinct (18.1% overlap). Among HIV-positive and HIV-negative respondents, tactical serosorting was 
associated with reduced condom use. Compared with respondents using RMA other than serosorting, 
HIV-positive men reporting serosorting had a three-fold increased risk for bacterial STI (strategic: odds 
ratio (OR) = 2.62; 95% confidence interval (CI): 1.76–3.89; tactical: OR= 3.19; 95% CI: 2.14–4.75; 
both for respondents without HIV seroconcordant partners).  
Conclusions: HIV serosorting has emerged as a common RMA among MSM. For HIV-positive MSM, 






In the past decade, surveys of sexual risk behaviour in men who have sex with men (MSM) in Western 
post-industrialised countries have demonstrated a number of trends.  
 
The frequency of anal intercourse with non-steady partners and the proportion of MSM with high 
numbers of sexual partners have increased. However, the frequency of HIV testing has increased as 
well and hence the precondition for communicating a recent HIV test result. Condom use in anal 
intercourse with partners of perceived concordant HIV serostatus has been declining.1–11 Unprotected 
anal intercourse (UAI) with presumably seroconcordant sexual partners has been labelled serosorting, 
especially with nonsteady partners, or negotiated safety with steady partners. Serosorting has the 
potential to reduce the frequency of UAI with serodiscordant partners.12 However, fundamental 
differences between HIV-positive and HIV-negative serosorting need to be considered: while an 
explicitly communicated positive HIV status is usually highly reliable information, a reported negative 
HIV status may or may not be true, either because people do not always tell the truth or because they 
have seroconverted since their last negative HIV test.13,14 However, explicit disclosure of a positive HIV 
status requires barriers posed by stigma and fear to be overcome.15 This means that serosorting of 
HIV-positive MSM comprises features of stigma management as well as risk management, while 
serosorting of HIV-negative men is predominantly risk management. Because meaningful disclosure of 
HIV serostatus requires a certain degree of mutual trust, intended serosorting – particularly if 
employed in the context of casual, often anonymous, partnerships – in practice may be described as 
seroguessing16,17 and is thus prone to error.  
 
  
Serosorting – especially if employed predominantly by MSM with many sexual partners or within larger 
sexual networks – may enhance epidemics of other sexually transmissible infections (STI) and thus 
contribute to an increase in the percontact transmission probability of HIV.16–27  
 
The estimated number of MSM newly diagnosed with HIV in Germany doubled from ~1100 in 2000–01 
to 2200 in 2008–09. Confronted with these increasing numbers, we designed and implemented a 
national survey on knowledge, attitudes and behaviour as to sexually transmitted infections (the 
KABaSTI study) for MSM. In this report, to explore the potentially unintended consequences of HIV 
serosorting, we aimed (1) to quantify the proportion of MSM reporting their intentions to serosort when 
asked about their personal HIV risk (or stigma) management approaches (RMA); (2) to describe the 
behavioural context, i.e. the association between serosorting and other RMA; and (3) to analyse the 
inter-relationship between serosorting and recent diagnoses of bacterial STI. In this analysis, we used 
reported intention to serosort as a surrogate for the practice of HIV serosorting, which is particularly 
difficult to measure by self-reported behaviour with non-steady partners. Measurement problems can 
arise from difficulties in capturing explicit and implicit serostatus communication between partners 
using a limited set of questions in a behavioural survey. Moreover, the validity of an HIVnegative 
serostatus reported during a sexual encounter is difficult to determine.  
 
Risk management approaches that imply selective condom use have not yet been consensually put 
into use in behavioural questionnaires. Therefore we contrast two different ways of querying 







The study used two approaches to recruit participants:  
 
(1) German languageMSMonline sexual networking sites were asked to provide a link to an online 
questionnaire in June 2006. Seven websites participated. The mode of advertisement ranged from 
individual messages to website users, to providing a prominent banner on the start page or providing a 
more hidden banner on a secondary page on health information.  
 
(2) More than 300 doctors in private medical practices (n = 318) who had reported syphilis infections 
among MSM since 2001 within the German infectious disease surveillance 
system were asked to participate in the study. Most STIrelated health care in Germany is provided by 
private practices (for men, mostly general practitioners, dermatologists and urologists, or, in larger 
cities, in specialised HIV centres). Participating practices (n = 76; 24%) received print questionnaires 
for distribution to all identifiable MSM clients from May to August 2006, regardless of the reason for 
consultation. Participants were asked to complete the questionnaire anonymously and to return it by 
mail postage prepaid.  
 
Thus, the sample frame was a convenience sample of German-speaking MSM aged 16 years and 
older. Material or monetary incentives for participation were not provided, neither to the MSM who 
participated in the study nor to private practices that recruited patients.  




An anonymous self-administered online and print questionnaire consisting of 66 items was used. The 
questions included sociodemographic data, current steady relationship with a man, sexual behaviour 
with steady partners and other partners, attitudes and risk management approaches regarding 
prevention of HIV and STI, history of STI, history of HIV testing, and – if tested for HIV antibodies – the 
last test result.  
 
Measures 
Serosorting is not an established concept that can easily be measured in behavioural surveys. Studies 
dealing with serosorting have to be compared with caution, as it is not always clear how it has been 
queried and put into use. In some studies, serosorting is seen as a more generalised way of seeking 
sexual contacts exclusively or preferably with partners of the same serostatus; while in other studies, 
  
serosorting is defined as non-use of condoms in a specific sex act because of assumed 
seroconcordance. We labelled the generalised approach strategic serosorting and the situational 
approach tactical serosorting.  
 
 
Questions analysed and definitions  
We included the following three questions on sexual behaviour in the previous 12 months into our 
analysis:  
 
(1) How many men did you have sex with in the previous 12 months? Response options were: none, 
1, 2–5, 6–10, 11–20, 21–50, 51–100 or more than 100.  
 
(2) How many of your sex partners in the previous 12 months were anonymous partners? (Anonymous 
means the only way to meet this person again would be by chance.) Response options were all of 
them, most of them, more than half, less than half, some of them or none of them.  
 
(3) Did you have anal intercourse without a condom in the previous 12 months with a sex partner 
whose HIV test result you did not know? If yes, how often did this happen in the previous 12 months? 
Response options were once or twice, 3–4 times, 5–10 times, every month, or every week or almost 
every week. The three following categories of partners for this question were: steady partner, non-
steady but known partner and non-steady previously unknown partner.  
 
Risk management approaches were queried with essentially two questions. In one multiple choice 
question, respondents were asked: ‘What is your response to the risk of infections during sexual 
contacts?’ We offered a choice of 12 responses; multiple responses were allowed. In another multiple-
choice question, participants were asked: ‘Under which conditions would you decide not to use a 
condom for anal intercourse?’ We offered a choice of eight responses; again multiple responses were 
allowed.  
 
All RMA included in statistical analyses are described and summarised in Table 1.  
 
Classification as HIV-positive or HIV-negative, or as currently being treated with antiretroviral therapy 
(ART) was based on self-reported information.  
 
A recent diagnosis of a bacterial STI was defined as self-reported syphilis, chlamydia infection, or self-




Both groups, strategic and tactical serosorters, were stratified (1) by HIV serostatus and (2) by the 
type of sexual partners. The concepts of steady and other partners were self-defined, but clearly 
separated in the questionnaire as different categories of sex partners. This stratification was deemed 
necessary because participants with a seroconcordant steady partner may have practiced negotiated 
safety (serosorting only within a relationship with a high reliability of serostatus information). As the 
questions on RMA, including serosorting, did not systematically distinguish between sexual contacts 
with steady and non-steady partners, the four serosorting strata of respondents who reported a 
seroconcordant steady partner were analysed separately from respondents who reported only 




Relationship between different dimensions of sexual risk management and HIV serosorting 
We grouped variables from the questionnaire into sexual behaviour (number of partners in previous 12 
months, proportion of anonymous partners, UAI with partners of unknown HIV serostatus) and risk 
management approaches with the following different dimensions of risk management: partner 
restriction (monogamy), partner selection (face check), condom use intentions (safer sex,A partner 
decision, extended condom use for STI prevention), restriction of active body fluid exchange 
(withdrawal) and positioning in anal intercourse (strategic positioning). We compared the two groups 
who reported serosorting intentions, stratified by HIV-serostatus, with their control groups with respect 





For this analysis, we included only those respondents who had answered the question on HIV-testing, 
who reported an HIV test result, and who had answered the questions on RMA and previous STI. 
 
For analysing of the impact of serosorting on the incidence of bacterial STI among the respondents, 
we calculated the odds ratio (OR) for reporting a bacterial STI within the previous 12 months for the 
various strata of strategic and tactical serosorters, and the respective control groups of respondents 
reporting RMA other than serosorting (i.e. this question was analysed in eight different strata of 
serosorters).  
 
We used multivariate logistic regression (SPSS 16; SPSS Inc., Chicago, IL, USA) for calculating 
adjusted OR to describe the relationship between sexual behaviour variables, RMA and serosorting 
(Table 3), and for reporting a recent diagnosis of bacterial STI (Table 4). Adjustments were made for 
age (stratified as 16–24 years old, 25–34 years, 35–44 years and 45 years or older) and recruitment 






After exclusion of respondents who did not meet the inclusion criteria, data from 2985 respondents 
could be analysed. Respondents who were excluded (n = 3665) had either not reported previous HIV 
testing, which basically was due to early dropout before reaching the question (n = 3371), or had not 
reported an HIV test result (n = 67) or had not answered the critical questions concerning serosorting 
approaches (n = 215) or diagnosis of STI in the previous 12 months (n = 12). 
 
The basic characteristics of the remaining respondents are presented in Table 2. Participants 
represented a broad spectrum of age (16–76 years) and geographical distribution. Approximately half 
of the HIV-positive online participants were recruited on a bareback website whose clients had an 
eight-fold higher HIV prevalence (54%) than clients of the other websites (7%).  
 
 
The behavioural context of HIV serosorting in survey respondents  
Sexual behaviour: number and type of sexual partners 
More than five male sexual partners within the previous 12 months were reported by 54% of the 
respondents, and more than 10 by 38%. The proportion of participants with more than 10 sexual 
partners was higher among HIV-positive men than among HIV-negative men (see Table 2). Among 
participants who were older than 24 years, 44% reported that the majority of their sexual partners were 
anonymous; in participants younger than 25 years, the proportion reporting a predominance of 
anonymous partners was only 22%. While there were differences in partner numbers between HIV-
positive and HIV-negative participants, the frequencies of sexual intercourse were very similar (data 
not shown). Partnership status had an impact on frequency of reported sexual intercourse. Men with a 
steady partner reported more frequent intercourse than men with exclusively non-steady partners. A 
minimum of one episode of UAI with a partner of unknown HIV serostatus was reported by 30.3% of 
HIV-negative and 49.8% of HIV-positive respondents. 
 
 
Attitudes towards safer sex, condom use, serostatus communication and partner selection 
When asked about their response to the risk of HIV and other STI, the majority of survey participants 
(71.9%) claimed to generally practice safer sex (no definition of safer sex was provided). The 
proportions for participants whose last HIV test result was negative and participants who reported 
being HIV-positive are shown in Table 2.  
 
A positive attitude towards condom use for prevention of STI other than HIV was expressed by the 
majority of survey participants living with HIV.  
 
Within steady relationships, communication about HIV status seemed to be common. Among HIV-
positive survey participants living in a steady relationship, 80.6% knew about the HIV serostatus of 
their partners (43.1% HIV seroconcordant; 37.5% HIV serodiscordant). Among HIV-negative 
participants, 75% were aware of an HIV test result of their partner (65.9% HIV seroconcordant; 9.1% 
HIV serodiscordant). We did not ask directly about HIV serostatus disclosure to non-steady partners. 
 
  
Self-reported history of STI 
Differences in self-reported history of bacterial STI in the previous 12 months were observed 
according to HIV serostatus (see Table 2) and ART. Among HIV-positive respondents, 71.2% were 
receiving ART. Recent bacterial STI were less frequently reported by respondents who were currently 
receiving ART than by respondents who did not (28.7% v. 43.9%; P < 0.001). 
 
 
HIV serosorting Frequency of HIV serosorting approaches 
HIV serosorting patterns were different among HIV-positive and HIV-negative participants, as shown in 
Table 2. Among RMA, tactical serosorting ranked second after RMA based on condom use.  
 
After stratification for seroconcordant relationships, there were 591 HIV-positive participants without a 
seroconcordant steady partner. Of these, 295 (49.9%) were classified as practicing tactical serosorting 
and 198 (33.5%) were classified as practicing strategic serosorting. Among these, 181 HIVpositive 
men were classified as both strategic and tactical serosorters.  
 
Among the 1456 HIV-negative participants without a seroconcordant steady partner, the overlap was 
smaller: 636 (43.7%) were classified as practicing tactical serosorting, and 181 (12.4%) were classified 
as practicing strategic serosorting. Among these, 125 HIV-negative men were classified as both 
strategic and tactical serosorters.  
 
Notably, 39% of HIV-negative participants and 34% of HIVpositive participants who reported 
predominantly practicing safer sex and had no seroconcordant steady partner said that they would not 




Relationship between different dimensions of sexual risk management and HIV serosorting  
Strategic and tactical HIV serosorting among HIV-positive respondents.  
Among HIV-positive respondents, the associations between strategic and tactical serosorting and 
other aspects of sexual risk management were highly consistent (see Table 3), reflecting the 
considerable overlap between the two groups. Compared with HIV-positive respondents with other risk 
management approaches than serosorting, both groups reported less safer sex, reduced condom use 
during anal intercourse with non-steady partners or for STI prevention, and higher numbers of sex 
partners; both were more likely to use strategic positioning and both were more willing to practice 
unprotected sex if their partner did not insist on condom use. 
 
Strategic and tactical HIV serosorting among HIVnegative respondents.  
Comparing HIV-negative strategic and tactical serosorting, the association between other forms of 
sexual risk management and serosorting was mixed (see Table 3). Compared with the control groups, 
both tactical and strategic serosorting were associated with the intention to restrict sexual activity to 
steady relationships, both were associated with checking out potential partners for signs of HIV, and 
both were associated with the belief that strategic positioning and withdrawal before ejaculation might 
reduce the risk for HIV infection. Differences were found regarding self-reported HIV risk taking: 
tactical (but not strategic) serosorting was associated with a history of five or more episodes of anal 
intercourse with non-steady partners of unknown HIV serostatus and was associated with accepting a 
partner’s decision not to use condoms; it was less often associated with the choice of safer sex as an 
RMA and with agreeing with the statement that condom use was necessary for protection against 
other STI. 
 
Impact of HIV serosorting on the risk for bacterial STI 
Among HIV-positive respondents, tactical and strategic serosorting was associated with a recent 
history of bacterial STI. This association was independent from the HIV serostatus of the steady 
partner. High OR were found for men without a seroconcordant steady partner, as well as for men who 
had been in a relationship with a man who was also HIV-positive. Contrastingly, no increased risk for 
bacterial STI was found among HIV-negative men who reported any kind of serosorting (see Table 4). 
 
 
Sensitivity analysis of the impact of recruitment sites 
All results reported in Table 2 remain qualitatively unchanged if we exclude men recruited on the 
bareback website from analysis, or if OR are not adjusted for recruitment site (Tables 3 and 4). 
  
However, the differences between HIV-negative and HIV-positive respondents (Table 2) and the 






Among German MSM, we found empirical evidence for a widespread use of risk management and risk 
reduction approaches other than condom use, primarily HIV serosorting. The proportions of 
serosorters in our sample are higher than reported from Australia,17 which may reflect a broader 
definition of serosorting in our analysis and sampling differences. Overlapping response patterns 
indicate that HIV serosorting in a context of non-steady partnerships was interpreted as being 
consistent with safer sex by many MSM. Like safer sex, these strategies focus predominantly on the 
risk of HIV and – with the exception of strategic serosorting in HIV-negative MSM (who qualified as 
avoiders of any contact with HIV-positives rather than serosorters) – were implemented as substitutes 
for consistent condom use. One may argue whether strategic serosorting in HIV-negative MSM as 
defined and described in our study is serosorting at all, since it does not seem to substitute condom 
use but appears to be used as an additional layer of safety by men who are very anxious to avoid the 
risk of HIV.  
 
Respondents appear to prefer establishing steady relationships with HIV seroconcordant partners. 
Among other reasons for preferring HIV seroconcordance in partnerships, this allows UAI without the 
risk of HIV transmission in the absence of HIV risk-taking with third parties. However, partnership 
status had no obvious impact on the rate of reported bacterial STI in the previous 12 months, either in 
HIV-positive or in HIVnegative MSM (see Table 4). This may be due to underrepresentation of men 
living in monogamous relationships in our sample, which was mainly recruited on dating websites. But 
outside of steady relationships, serosorting was employed for HIV risk management and, for HIV-
positive men, presumably rather for stigma management. HIV seroconcordance was the most 
frequently cited reason for the intention of not using condoms during anal intercourse. HIV-negative 
men, who reported tactical serosorting as a reason for not using condoms with an assumed 
seroconcordant partner, often had a current steady partner. We were not able to clearly differentiate 
how much of this serosorting was actually negotiated safety, as we could not determine whether a 
decision for not using condoms with the steady partner was the result of a process of mutual 
disclosure of each other’s HIV serostatus and explicit negotiation of the rules of conduct with other 
partners outside of the steady relationship.  
 
While online communication may reduce the threshold for more explicit and implicit serostatus 
disclosure for HIV-positive men outside of steady relationships,28–31 different meanings and 
interpretations of codes and surrogates used for HIV serostatus determination may occur during online 
communication, and have been described.16,31 Even more difficult and prone to error is the 
establishment of HIV seroconcordance between presumably HIV-negative men meeting online, and 
especially with anonymous non-steady partners met offline.17,32 The readiness for not using condoms 
‘if the partner does not insist on condom use’, which, in our survey, was notably reported by HIV-
positive as well as HIV-negative respondents, indicates a lack of explicit communication of HIV 
serostatus16 and a readiness to base condom use decisions on weakly founded assumptions.  
 
Prevention campaigns will have to address this kind of nonnegotiated unsafe behaviour with 
messages stressing that assumptions about the HIV serostatus of potential sexual partners should not 
be based on their willingness to insist on condom use.  
 
We could show that HIV serosorting among HIV-positive men, according to both of our definitions, was 
associated with a significantly increased incidence of STI. The high incidence of STI is mediated by 
high partner numbers, reduced condom use and the high prevalence of STI within the sexual networks 
of HIV-positive people who serosort. The high STI incidence among HIV-positive men also supports 
the assumption that the positive attitudes towards serosorting that we captured by our questions 
reflect HIV stigma management rather than effective management of sexual risks.  
 
Among HIV-negative men, tactical serosorting with nonsteady partners was associated with reduced 
condom use and strategic positioning. While we did not find an increased incidence of bacterial STI, 
this may still confer considerable risks for the acquisition of HIV, particularly in sexual networks and 
  
situations where explicit HIV status disclosure is unusual (e.g. if people refer to partner decision on 
condom use).  
 
Due to the large overlap between strategic and tactical serosorting among HIV-positive MSM and the 
considerable differences between the two concepts among HIV-negative MSM, it may be advisable to 
focus in future studies on the interrelationship between HIV serosorting and transmission 
risks of HIV and STI on the concept of tactical serosorting, which seems to be more problematic in 
HIV-negative MSM in terms of HIV transmission risk than strategic serosorting.  
 
It should be mentioned that the self-reported rates of bacterial STI in our sample almost certainly 
reflect a considerable underdiagnosis. 33 While relying on self-reports of bacterial STI is a  limitation of 
this analysis, we still believe that different selfreported STI rates reflect actual differences of STI 
incidence, because at least at the time of the survey (2006), screening for asymptomatic anorectal and 
pharyngeal infections with Neisseria gonorrhoeae and Chlamydia trachomatis was highly unusual in 
Germany, even for HIV-positive men in regular care at HIV specialists.  
 
There are a few more limitations for our findings. Our survey participants are a convenience (i.e. non-
representative) sample of German-speaking MSM: by recruiting participants in medical practices and 
by including a bareback website, we intentionally oversampled HIV-positive participants (HIV 
prevalence in our sample was ~2–2.5-fold the estimated average prevalence in MSM in Germany34,B), 
and participants with a higher than average level of sexual risk behaviour and consequently a higher 
than average incidence of STI. HIV-positive and HIVnegative MSM who restrict their sexual activity to 
a steady relationship or who are not sexually active at all are certainly under-represented in our 
sample. Other limitations are biases in the sample, especially in terms of educational and professional 
status, not so much in geographical and age distribution. Compared with the general male population 
of Germany, men older than 50 years and MSM with immigrant backgrounds were under-represented. 
The sample was also affected by a middle-class bias, which is typically seen in convenience samples. 
It may be that MSM from lower social classes or other subgroups of MSM who are not reached by 
internet surveys show different patterns of risk management approaches.  
 
We do not believe that oversampling of HIV-positive participants, and participants with a higher level of 
sexual risk behaviour entails a problem for our analysis. Our aim was the analysis of tactical and 
strategic serosorting as risk management approaches among MSM, the description of the behavioural 
context in which serosorting occurs and the relationship of the different forms of serosorting with the 
specific outcome of frequencies of bacterial STI. By oversampling participants with higher risk levels, 
we could do more detailed subgroup analyses, e.g. comparing HIVpositive and HIV-negative 
participants with different risk management strategies and tactics, and different relationship statuses. 
This view is supported by the sensitivity analysis where we excluded participants recruited on the 
bareback website. This analysis showed that the results remain essentially unchanged. Not 
surprisingly, HIV-positive MSM recruited on the bareback website reported less safer sex, less 
monogamy and more HIV serosorting than HIV-positive MSM recruited on other websites or offline. 
Since serosorting for HIV-positive MSM is a form of stigma management, serosorting is easier and 
more efficient on a bareback website than on general MSM websites due to the high proportion of HIV-
positive users. Thus we do not believe that HIV-positive respondents recruited on bareback sites 
should or need to be excluded from analysis. If we still adjust for recruitment site in our multiple 
regression analysis, we arrive at a rather conservative estimate of the impact of serosorting on the risk 
for bacterial STI.  
 
Taken together, HIV serosorting has emerged as the preferred RMA among MSM who are (already) 
HIV-positive, and hence, can – at least theoretically – serosort comparably effectively. However, UAI, 
in the context of HIV serosorting, amplifies the incidence and prevalence of STI other than HIV and 
thus increases the per-contact risks for HIV transmission during serodiscordant sexual encounters – 
particularly in the subgroup of HIV-positive men who are not yet undergoing ART.18,20,21,25,33 The high 
self-reported incidence of bacterial STI among HIV-positive men points to the problem that HIV 
serosorting may be stigma management rather than sexual risk management, and suggests a serious 
lack of a comprehensive and adequate STI prevention strategies for this group.  
 
While the importance of prevention activities targeted at HIV-positive persons has repeatedly been 
emphasised,35–37 most proposals relate to activities within the medical care system. However, persons 
who are not yet eligible for ART appear less frequently in the health care system and would thus be 
more difficult to reach by such activities. However, most of the HIV-positive persons already receiving 
ART have an effectively suppressed viral replication and thus probably do not represent an important 
  
source of onward transmission of HIV – although the extent of HIV transmission risk reduction in the 
context of concomitant STI is controversial.38–42 In any case, our findings suggest that comprehensive 
screening and treatment for STI should be integrated into routine HIV care for sexually active HIV-
positive MSM.  
 
Our data and other reports on the increasing incidence and prevalence of bacterial STI among HIV-
positive MSM43 raise doubts about the frequently cited claim that knowledge of one’s HIV infection 
status reduces risky sexual behaviour in the longterm.44 At least in our MSM sample, a main 
component of the changes in risk behaviour is HIV serosorting; serosorting, even if successful, 
addresses only the risk of HIV and may have contrary effects on the risk for other STI.  
 
In the long-term, our finding of severe unintended side effects of HIV serosorting raises the question 
how gay communities should deal with the prospect of a slowly but continuously increasing prevalence 
of HIV in the coming years. A vision other than dividing the gay community socially and sexually into 
people who are HIV-positive and HIV-negative may be needed. 
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Table 2 Basic characteristics of survey participants according to reported HIV serostatus, sexual 
behaviour and selected risk management approaches among respondents with a previous HIV test 
 
 
A Five or more episodes of unprotected anal intercourse with non-steady partners of unknown HIV 


















Table 3 Relationship of strategic and tactical serosorting with other risk management approaches 
Age and recruitment site adjustedA odds ratios with 95% confidence intervals. HIV-positive and HIV-
negative strategic and tactical serosorters were compared 
with their respective non-serosorting control groups, after exclusion of all respondents who reported a 





A Odds ratios are adjusted for age groups 16–24 years (n = 258), 25–34 years (n = 608), 35–44 years 
(n = 764) and 45+ (n = 417), and for recruitment site. 
B Non-significant at alpha = 0.95. 
C Non-steady partners are predominantly anonymous partners. 
D Five or more episodes of unprotected anal intercourse with non-steady partners of unknown HIV 
serostatus. 
E Sexual behaviour in the past 12 months. 
 
Example: HIV-negative tactical serosorters have three-fold higher odds of reporting five or more 
episodes of unprotected anal intercourse with non-steady partners of unknown HIV status compared 




Table 4 Self-reported bacterial sexually transmissible infections (STI) in the previous 12 months in 
different strata of serosorters compared with non-serosorting control groups 
 
Age- and recruitment site-adjusted odds ratio with 95% confidence intervals. HIV-positive and HIV-
negative strategic and tactical serosorters with and without seroconcordant partners were compared 
with their respective non-serosorting control groups. Odds ratios are adjusted for age groups 16–24 





A Non-significant at alpha = 0.95. 
  
